![Kevin Johnson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Johnson
Conseiller Juridique Général chez
Tourmaline Bio, Inc.
Profil
Kevin B. Johnson is Chief Regulatory Officer at Tourmaline Sub, Inc. since 2023.
Formerly, Dr. Johnson was Chief Regulatory Officer at Tourmaline Bio, Inc. from 2023 to 2025, Chief Regulatory Officer at Ring Therapeutics, Inc. from 2021 to 2022, Senior Vice President-Regulatory Affairs at Inozyme Pharma, Inc. from 2020 to 2021, Senior Vice President, Head-Regulatory & Quality at Magenta Therapeutics, Inc. in 2020, Senior Vice President & Head-Regulatory Affairs at Imara, Inc. from 2018 to 2020, Vice President, Global Head- Regulatory & Quality at Sucampo Pharmaceuticals LLC from 2017 to 2018, and Global Head-Regulatory Affairs at Novella Clinical, Inc. Education includes undergraduate degree from the University of South Florida, MBA from Kenan-Flagler Business School, and doctorate from UNC School of Medicine.
Postes actifs de Kevin Johnson
| Sociétés | Poste | Début |
|---|---|---|
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Conseiller Juridique Général | 19/10/2023 |
Anciens postes connus de Kevin Johnson
| Sociétés | Poste | Fin |
|---|---|---|
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Conseiller Juridique Général | 01/12/2022 |
| INOZYME PHARMA, INC. | Conseiller Juridique Général | 01/01/2021 |
| MAGENTA THERAPEUTICS | Public Communications Contact | 01/11/2020 |
| IMARA | Conseiller Juridique Général | 01/09/2020 |
Formation de Kevin Johnson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Novella Clinical, Inc.
 Novella Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research development solutions | Commercial Services |
Kenan-Flagler Business School
 Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UNC School of Medicine
 UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Commercial Services |
